In order to conduct postmortem human brain research into the neuropathological basis of schizophrenia, it is critical to establish cohorts that are well-characterized and well-matched. The aim of the present study was therefore to determine if specimen characteristics including: diagnosis, age, postmortem interval (PMI), brain acidity (pH), and/or the agonal state of the subject at death related to RNA quality, and to determine the most appropriate reference gene mRNAs. Methods: A matched cohort was selected of 74 subjects (schizophrenia/schizoaffective disorder, n = 37; controls, n = 37). Middle frontal gyrus tissue was pulverized, tissue pH was measured, RNA isolated for cDNA from each case, and RNA integrity number (RIN) measurements were assessed. Using quantitative reverse transcription-polymerase chain reaction, nine housekeeper genes were measured and a geomean calculated per case in each diagnostic group. Results: The RINs were very good (mean = 7.3) and all nine housekeeper control genes were signifi cantly correlated with RIN. Seven of nine housekeeper genes were also correlated with pH; two clinical variables, agonal state and duration of illness, did have an effect on some control mRNAs. No major impact of PMI or freezer time on housekeeper mRNAs was detected. The results show that people with schizophrenia had signifi cantly less PPIA and SDHA mRNA and tended to have less GUSB and B2M mRNA, suggesting that these control genes may not be good candidates for normalization. Conclusions: In the present cohort <10% variability in RINs was detected and the diagnostic groups were well matched overall. The cohort was adequately powered (0.80-0.90) to detect mRNA differences (25%) due to disease. The study suggests that multiple factors should be considered in mRNA expression studies of human brain tissues. When schizophrenia cases are adequately matched to control cases subtle differences in gene expression can be reliably detected.
Schizophrenia research on postmortem human tissue has matured in the past decade, largely due to two factors: (i) the widespread availability of larger cohorts that are more extensively screened; and (ii) the readily available quantitative molecular tools especially for gene expression studies. In the past, lack of replication of basic biological fi ndings in brains of people with schizophrenia across laboratories hampered progress. The renewed research effort on postmortem brains is fi nally yielding numerous replicable fi ndings across independent laboratories and of knowledge, skills and techniques together to fi nd ways to prevent and cure schizophrenia [18] . In 2007, through the Institute's Developmental Neurobiology Panel, SRI commenced a process of actively facilitating the development of a large-scale collaborative research programme based on the use of a common collection of postmortem brains for schizophrenia research from the Tissue Resource Centre at the University of Sydney. The results from this multifaceted investigation will be collected and collated, thereby allowing for testing of relationships among a variety of measures. This report represents the fi rst step in this collaborative process whereby the collection and quality control processes for this new SRI tissue cohort are described and the selection of reference genes is considered.
Methods

Subjects
All research was approved and conducted under the guidelines of the Human Research Ethics Committee at the University of New South Wales (HREC 07261). The study cohort included 37 schizophrenia/ schizoaffective disorder patients and 37 matched controls ( Table 1) . Controls were selected prior to RNA extraction based on the following parameters (in descending order of importance for matching), brain pH (Ϯ1), age at death (within 10 years), and postmortem interval (PMI; within 10 h). Other factors such as hemisphere, gender, time in freezer and agonal state were matched on a stratum (groupwise) basis.
Details of brain collection and determination of clinical and tissue factors can be found in Supplementary Materials and Methods, and in Tables 1S, 2S . Supplementary material to be found online, at http//www. informaworld.com/10.1080/00048670903393662. independent cohorts, which is a critical advance for postmortem brain research on schizophrenia. Studies of postmortem human brain provide a valuable avenue for elucidating the underlying cellular and molecular mechanisms of schizophrenia that are not accessible through live imaging of people or through animal models. Thus, there is a need for direct studying of postmortem human brains from people with schizophrenia, although collecting and characterizing human brains is methodologically challenging [1] [2] [3] , and standards regarding inclusion criteria necessary for rigorous postmortem research are not universally agreed upon and continue to change [4] [5] [6] [7] [8] [9] [10] [11] . Numerous premortem, antemortem and postmortem factors can infl uence the quality of human brain tissue and need to be considered, and the relative importance of confounding factors for specifi c molecules are often not known.
Despite these limitations, postmortem human studies of psychiatric illnesses such as schizophrenia remain an extremely valuable tool because they have already begun to shed light on a number of molecular mechanisms that contribute to the aetiology and development of schizophrenia [12] [13] [14] [15] [16] [17] . The establishment of multiple large cohorts of wellcharacterized brains of people with schizophrenia and controls from around the world contribute to our understanding of the biological basis for schizophrenia and will be critical to advancing the fi eld. Therefore, given our experience, and with access to a fairly large collection of postmortem tissue samples, we set out to establish a new cohort of schizophrenia and control brains from Sydney, Australia.
The assembly and characterization of this cohort has been driven by the Schizophrenia Research Institute (SRI), a virtual institute supporting the collaboration of Australian scientists and clinicians who bring a variety Cynthia Shannon Weickert, Macquarie Chair of Schizophrenia Research (Correspondence) well format (Applied Biosystems, Foster City, CA, USA) and TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA; Table 2 ). Samples were run with a seven-point standard curve using serial dilutions of pooled cDNA derived from a representative sample of subjects (three controls and three patients). The no-template control did not produce a signal in any assay. All amplifi cations from each subject were performed in triplicate and relative quantities were determined from the standard curve. Outliers due to measurement errors were omitted if the percent variance of the triplicates was Ͼ30% of the quantity mean value as previously described [21] [22] [23] and the mean re-calculated based on two values (this occurred in Ͻ5% of the samples).
Stability of mRNA expression was measured using the program geNorm VBA applet for Microsoft Excel version 3.5, developed by Vandesompele et al., in which more stable genes will have a lower M [24] .
Statistical analysis
Statistical analyses were conducted using Statistica version 7 (StatSoft, Tulsa, OK, USA). After measurement errors were removed, population outliers were determined and samples Ͼ2SD from the mean for each group were removed (on average 1-2 subjects per group). We also defi ned population outliers using the Grubb's test, which yielded similar results. Both paired and non-paired Student's t-tests were used to determine if the diagnostic groups differed on individual housekeepers or geomean. To maximize power, the analyses were carried out with the schizophrenia patients combined with the schizoaffective patients as a single diagnostic category, but it is recognized that other analyses focusing only on the schizophrenia group are also planned. Correlations were run on continuous variables to determine if any of the demographic factors (age, pH, PMI or RIN) related to housekeeper mRNA levels or their geometric mean. If this was the case, analysis of covariance (ANCOVA) was used. Independent t-tests were conducted to examine whether gender or hemisphere were related
RNA extraction and quality assessment
Grey matter tissue from dorsolateral prefrontal cortex (DLPFC) was pulverized over dry ice. Approximately 300 mg was weighed while frozen and stored at -80°C until extraction. Total RNA was extracted with TRIzol Reagent (Cat. No. 15596-018; Invitrogen Life Science, Melbourne, Vic., Australia), using a polytron as previously described [19] . Total RNA pellets were resuspended in DEPC-treated water (Cat.
No. 95284-100ML; Sigma-Aldrich, Castle Hill, NSW, Australia). The yield of total RNA was then analysed using a spectrophotometer (Nanodrop ND-1000; Thermo Scientifi c, Wilmington, DE, USA). Total RNA was not further purifi ed through a column. The quality of extracted total RNA was determined on high-resolution capillary electrophoresis using an Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Approximately 100-200 ng RNA was applied to an RNA 6000 Nano LabChip (Ajilent Technologies, Waldbronn, Germany), without heating prior to loading, and subsequent steps performed according to the manufacturer's protocol. Two internal controls (samples with established high-quality RNA integrity number (RIN) ϭ 10)
were loaded on each chip, and all samples analysed on the same day.
The RIN was calculated using an algorithm incorporating information from the entire electrophoretic trace and used as an indicator of RNA quality, ranging from 1 (lowest quality) to 10 (highest quality) [20] .
Three separate aliquots of total RNA were used to synthesize cDNA from 3 μg of total RNA in a 26.25 μL reaction using the SuperScript First-Strand Synthesis kit (Invitrogen, Carlsbad, CA, USA) and were pooled to reduce any potential variability in cDNA reactions prior to diluting for reverse transcription-polymerase chain reaction (RT-PCR). 
Quantitative reverse transcription-polymerase chain reaction
Transcript stability and calculation of geometric mean
We determined that ACTB and GADPH were the two most stable genes generating the lowest M, and that B2M and GUSB were the least stable genes with the highest M ( Figure 2A ). Pairwise variation analysis suggests that using the two most stable housekeeping genes (ACTB and GADPH) is suffi cient to determine the normalization factor because V2/3 is below the suggested threshold of 0.15 ( Figure 2B ) [24] . For the purposes of normalizing the data to housekeeper control genes, however, we chose a further two genes because it has also been recommended that genes used for normalization are not signifi cantly altered in schizophrenia compared to controls, and represent transcripts of different levels of expression. We chose four genes, two (ACTB and GAPDH) with higher expression levels, one (UBC) being in the midrange of expression, and one (TBP) with lower expression levels [25] .
When the geomean was recalculated using these four housekeeping genes (herein geomean(4)) and outliers removed (one case removed) we did not detect a signifi cant difference between the normalizing factor geomean in patients with schizophrenia compared to controls (unpaired t-test, t ϭ 0.82, df ϭ 71, p ϭ 0.415; paired t-test, t ϭ -0.79, df ϭ 35, p ϭ 0.420; Figure 3A ). to housekeeper gene expression. Factorial ANOVA was used to determine the effect of gender or hemisphere on gene expression in the diagnostic groups. Statistical signifi cance was set at p ≤ 0.05. Significance level is reported as p rounded to three signifi cant fi gures.
Results
Matching of diagnostic groups
The patients with schizophrenia and schizoaffective disorder (n ϭ 37) were on average 51 years old, with a brain pH of 6.61 and a PMI of 28.8 hours ( Table 1 ). The normal control subjects selected to match these patients (n ϭ 37) had an average age of 51 years, a brain pH of 6.66 and a PMI of 24.8 hours. The mean RINs were 7.3 for both groups and had a low coeffi cient of variation (between 7.8 and 8.0%). As anticipated age, pH, PMI, freezer storage time, and RIN did not differ signifi cantly between the groups (all t Ͻ 1.3, all p Ͼ 0.210). Freezer storage time of brain tissue for patients averaged 81 months and did not differ statistically as compared to normal controls at 70 months. The number of men was higher than women in both groups, although the number of men was slightly lower in the schizo- 
Relationship of demographic variables to each other and RIN
The subjects spanned a considerable age range (18-78 years) and we found that age at death negatively correlated with the overall brainweight (r ϭ -0.32, p ϭ 0.005, n ϭ 74), overall brain volume (r ϭ -0.26, p ϭ 0.026, n ϭ 74), DLPFC pH (r ϭ -0.27, p ϭ 0.018, n ϭ 74) and RIN (r ϭ -0.27, p ϭ 0.020, n ϭ 74; Figure 1 ). As expected, women (n ϭ 20, 1300 mL) had smaller brains as compared to men (n ϭ 54, 1468 mL, t ϭ 5.13, df ϭ 72, p Ͻ 0.001), and women (1288 g) had lighter brains as compared to men (1469 g; t ϭ 5.55, df ϭ 72, p Ͻ 0.0001).
Patients with schizophrenia (1394 g) had a lighter brainweight compared to non-affected controls (1446 g) although this difference was not statistically signifi cant (t ϭ -1.53, df ϭ 72, p ϭ 0.131). People with schizophrenia tended to smoke (n ϭ 23) rather than not smoke (n ϭ 7) and were more likely to be confi rmed smokers than controls (n ϭ 9). Smokers tended to have lower brain pH in both frontal cortex (6.63 vs 6.66) and cerebellum (6.45 vs 6.57), and frontal cortex RIN was marginally lower in the smokers (7.2 vs 7.3). The pH and RINs in the smokers and non-smokers, however, did not differ statistically.
As expected, the RIN measurement for DLPFC total RNA positively correlated with brain pH taken from the same tissue (r ϭ 0.39, 
RNA integrity number
Postmortem interval
Of the housekeeper control mRNAs, most of the housekeeper genes and the geomean(4) were not correlated with PMI ( Figure 3F ; all
Correlation of demographic variables and housekeeper mRNAs
Age When considering the whole cohort, the expression of six of nine housekeeping genes correlated negatively with age at death (SDHA: (r ϭ -0.28, p ϭ 0.018; Figure 3B ). When we explored which diagnostic group contributed more to these overall correlations, we found that the normal group did not show any signifi cant correlations with any housekeeper control genes or geomean(4) and age at death (all p Ͼ 0.08). In contrast, the expression of fi ve of nine housekeeping genes and geomean(4) correlated negatively with age in schizophrenia patients only (SDHA: r ϭ -0.45, p ϭ 0.006; Figure 2 . Average expression stability and optimal number of housekeeper genes for normalization determined using the program geNorm. (A) Genes were ranked according to average expression stability. ACTB and GAPDH were the most stable genes (lowest M), while GUSB was the least stable gene (highest M).
(B) Pairwise variation with the stepwise addition of more housekeeping genes shows that the use of the two most stable housekeeping genes will be suffi cient for accurate normalization because this satisfi es the cut-off (0.15 M) recommended by Vandesompele et al. [24] . 
Diagnostic differences in housekeeper control mRNA
T-tests
In the present study we found approximately 30% coeffi cient of variation in housekeeper mRNA in both groups (Table 3) , which is less variable than previously found [6] . Surprisingly, we found that some housekeeping control genes were reduced in the DLPFC of patients with schizophrenia by as much as 10-15% ( Figure 4A ). We found that Figure 4B ). After ANCOVA 
Consideration of clinical variables
The 
Effects of hemisphere and gender on geomean(4)
We found that there was a main effect of hemisphere on the geomean (4) appears to be the most critical factor for matching schizophrenia cases and controls [6, 26, 27] . But because RIN measures are available only after RNA isolation, we found that tissue pH can be used as a general guide to select potential controls to match to cases prior to RNA isolation [26, 27] . Because cerebellar and cortical pH correlate, determining cerebellar pH may be a valuable fi rst step in evaluating the suitability of cases for RNA analysis [26, 28] , but high tissue pH does not always indicate good RNA [26, 27] , and low pH does not necessarily yield low-quality RNA. The current cut-off for what is an acceptable RIN varies considerably, with some studies suggesting that a moderate amount of degradation and a RIN as low as 3.8-4.0 may be usable [6, 8, 29] . Also, it should be mentioned that RINs are typically higher after total RNA is purifi ed by columns, but this purifi cation step would exclude some small RNAs of interest such as microRNAs, and thus columns were not used in the present study. Ultimately, the cut-off for a usable RIN would depend on criteria set by the end user depending on the assay used and the molecule of interest, and thus, will vary. Earlier studies emphasized the importance of matching for tissue pH and RIN, and we have prioritized tissue pH, RIN, and age as variables to control for in assembling a cohort of schizophrenia and normal brains that are pair-selected within ranges, creating a closely matched and well-powered cohort. Most brain banks attempt to collect cases with the shortest PMI possible, although researchers have challenged the importance of PMI in determining RNA quality [6, [30] [31] [32] [33] . A number of studies suggested that PMI has no correlation or only a weak correlation with RNA quality [10, [26] [27] [28] . Studies that have examined human tissue collected during neurosurgery for epilepsy with minimal delay shows that the freshly acquired brain tissue pH and RIN are comparable or even lower to that collected after death [10, 26] . In agreement with these The relationship of brain volume with duration of illness and lifetime CPZ estimates reached trend levels of signifi cance (p ϭ 0.060-0.084, n ϭ 37). The only control mRNA that showed a statistically signifi cant correlation with any medication measure was UBC with the last recorded CPZ (r ϭ -0.36, p ϭ 0.048, n ϭ 31). Duration of illness did, however, negatively correlate with SDHA and ACTB (r Ͼ -0.37 p ϭ 0.028, n ϭ 35; r ϭ -0.38, p ϭ 0.022, n ϭ 36, respectively) mRNA expression, and with the geomean(4) (r ϭ -0.35, p ϭ 0.034, n ϭ 36; Figure 5C ). Because these same dependent variables correlated with age in the people with schizophrenia only, we ran partial correlations with age and found that only SDHA mRNA retained a relationship with duration of illness at a trend level (r ϭ -0.32, p ϭ 0.066).
Power analysis
Power calculations, performed using means and standard deviations of housekeeping genes in controls and patients with schizophrenia, were used to determine the sample sizes required to reject a null hypothesis of no difference in housekeeping gene expression between diagnostic groups. Power analysis indicated that the present cohort contained a suffi cient sample size to detect a 1.5-fold difference in the mRNA expression of all housekeeping genes between patients and controls, with 90% statistical power (α ϭ 0.05), requiring between six and 12 samples per group to detect this fold change. Additionally, we had suffi cient sample size to detect a 1.25-fold change in expression for all of the genes at 80% power and for six of nine genes at 90% power (Table 4 ). To detect a 1.1-fold difference with 90% statistical power would require 141-299 samples per group or, relaxing stringency to 70% statistical power, 83-176 samples per group (Table 4 ).
Discussion
Some consensus concerning the effects and relative importance of premortem and postmortem factors on human brain RNA quality is emerging. We fi nd, as others do, that RIN is a powerful indicator of mRNA levels and state (prolonged death) the lower the brain pH; but we did not fi nd an overall effect of agonal state on RIN. This agrees with studies that show that as agonal state scores increase, the tissue pH decreases [27, 28, 45] , but RIN may not differ signifi cantly with agonal state [27] . We did fi nd a lower value for geomean(4) with higher agonal state scores. Prolonged agonal state can downregulate some mRNAs (energy metabolism genes), while increasing others (stress response and infl ammation control genes) [45] , suggesting that agonal state is an important factor to consider when matching samples or groups of samples. Studies of the effects of aging on housekeeper gene expression in the human brain have led to the conclusion that age at death infl uences mRNA expression, especially when individuals span a large age range [6, 40] . In the present study, individuals spanned six decades of life with an average age of 51, which is comparable to several other cohorts used to study people with schizophrenia compared to controls [6, 46] . One of the surprising fi ndings of the present study was that fi ve of nine housekeeper control genes and the geomean(4) negatively correlated with age in the schizophrenia patients only. We also found that women but not men with schizophrenia had signifi cantly smaller brains with increasing age. Lighter brains in both sexes with schizophrenia has been reported previously [47] , but the neurobiological underpinnings of this are not understood. We also found that overall brainweight and brain volume negatively correlated with the mean daily dose of neuroleptic medication and duration of illness, suggesting that the longer someone was ill or the higher the dose of daily neuroleptics, the lower the brainweight and the smaller the brain at death. Patients with a longer duration of illness tended to have higher average lifetime antipsychotic dose, higher antipsychotic dose at the time of death, and lower housekeeper mRNA expression. Because the clinical measure of duration of illness is linked to age at death, we attempted to control for the effect of age by using partial correlation and found that SDHA mRNA correlated negatively with duration of illness at a trend level. The fact that the correlations between duration of illness and housekeeper gene mRNAs are no longer statistically signifi cant is diffi cult to interpret because age is not independent from duration of illness and thus some of the true variance coming from the duration of illness will be subtracted in the partial correlation for age. This is also true for earlier reports that partialled out the effect of age and failed to fi nd an effect of duration of illness on brainweight using meta-analysis [47] . The fact that older people with schizophrenia with a longer duration of illness have smaller brains and have decreased control mRNAs suggests that the longer someone lives with schizophrenia the greater published fi ndings, we found no correlation between PMI and most of the RNA quality measures in the DLPFC [26, 34] , with only one slight negative correlation with SDHA as previously described [6] . A microarray study in mouse brain tissue identifi ed Ͼ1000 transcripts that are degradation susceptible (labile) with increasing PMI, but they found that increased PMI does not affect GADPH mRNA levels [35] . Other studies in human brain suggest that another housekeeper control gene, B2M, is highly labile [36, 37] . On one hand, B2M may serve to correct for degradation levels if used to normalize genes of interest; on the other hand, we found that B2M is a fairly unstable housekeeper control gene and thus, we would not recommend it as a good control for schizophrenia studies. Other studies in humans suggest that some housekeeper transcripts are slightly infl uenced by PMI, especially in the hippocampus [6] , although this may not be the case for all hippocampal housekeeper RNAs [28] . Thus, although effects of PMI need to be evaluated for particular transcripts of interest through correlational analyses, PMI is unlikely to be a major determinant of RNA or transcript quality and may be helpful but not critical to consider when matching samples.
In contrast, it has been well demonstrated that tissue pH infl uences mRNA preservation in postmortem tissue [6, 32, 38, 39] . In the present study we found that the majority of housekeeper RNAs assayed and the geomean(4) correlated strongly with tissue pH. Studies that have measured the same housekeeper controls have also found positive correlations with brain tissue pH [6, 40] . Some previous reports suggest that a pH cut-off (pH Ͻ5.9-6.0) can be used as a screen to choose from which brains to extract RNA and analyse further [4] , or that tissue pH could be used as a critical lower threshold for transcriptome analysis (pH range 6.54-6.8) [28, 41] . Because most postmortem samples used here and in other current cohorts span a large pH range [6, [26] [27] [28] , with as many as 39-56% of subjects from psychiatric groups having a pH Ͻ6.5 [8] and as many as 28% of the present current sample, it would not be reasonable to exclude this large number of cases. Thus it is of critical importance to either pair-match for, or group (stratum) match for tissue pH. Several research groups have noted that pH is not always a reliable predictor of RNA quality and we fi nd that the individual with the lowest brain pH (5.7) had a RIN of 6.2. Hence, we agree with the recommendation that RNA isolation and RIN quality assessment should be completed on all samples before precious material is excluded from cohorts based on tissue pH alone [6, 27] .
The importance of agonal state in postmortem research has been increasingly recognized over the past several decades [36, [41] [42] [43] [44] . We found that the longer the agonal fl exibility because respiratory chain diseases most often affect muscle and the central nervous system (CNS) [67] . CNS symptoms can include epilepsy, demyelination, dementia and psychosis. Oxidative stress related to alterations in metabolism linked to mitochondrial distress has been observed in schizophrenia [43, [68] [69] [70] . GUSB, or glucuronidase-β, mRNA encodes a protein that is required to degrade glycosaminoglycans (i.e. heparin sulphate), and genetic changes in GUSB can result in deafness, behavioural defi cits and mental retardation [71] . Thus, although certain genes are chosen to represent the integrity of the transcript pool and are thus used as housekeeper control or reference genes, they can have a critical function in brain as evidenced when mutated. The question regarding whether slightly lowered reference gene transcript levels have any functional significance requires further investigation. The present study suggests that GUSB, PPIA and SDHA mRNAs are not optimal choices for reference genes in schizophrenia studies.
Taken together, the present data suggest that although only a small amount of variance in RNA quality or housekeeper mRNA level is explained by any one demographic (age) or tissue characteristic (pH), their effects are consistent across many laboratories and represent known confounders/covariates that can be controlled for when constructing postmortem cohorts. We suggest that matching diagnostic groups minimally for age, pH and RIN may help to resolve differences in gene expression that occur in schizophrenia as either a cause, a compensation or a consequence of the disease state [17] .
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the chance that they have accumulated deleterious impacts on their brain. This observation, although made on crosssectional data across the lifespan, fi ts well with volumetric studies showing decreased grey matter volume over time in people suffering from chronic schizophrenia [48, 49] .The present data suggest that some of these deleterious effects may be linked to antipsychotic medication effects, or at the very least are not prevented by current treatment strategies. Recent reports suggest that chronic antipsychotic use (both typical and atypical) causes a 10% decrease in brainweight and does in fact decrease cortical brain volume in controlled stereological studies of non-human primates [50, 51] . This volume reduction was linked to a signifi cant reduction in astrocytes and oligodendrocytes, a fi nding that parallels the reduction in astrocytic and oligodendrocyte markers found in some [52] [53] [54] [55] but not all [56, 57] postmortem studies of people with schizophrenia.
In the present study we found that two housekeeper genes, β-actin and GAPDH mRNAs, do not differ between people with schizophrenia compared to control as previously found [58, 59] , and the present data suggest that both are particularly stable mRNAs and useful housekeeping control genes for postmortem human brain studies. It should be emphasized, however, that the utility of GAPDH as a control varies from brain collection to brain collection, because some laboratories fi nd GAPDH to be stable and to not differ in people with schizophrenia as compared to controls, as we have done [59, 60] , while others suggest that it is one of the least stable and thus, least reliable control genes [22, 61] . We found that three putative housekeepers, GUSB, PPIA, and SDHA, are lower in people with schizophrenia. PPIA, and SDHA mRNA differences reached statistical signifi cance and both of these housekeeper mRNAs may be regulated by cellular stress. PPIA encodes a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family, which is a cyclosporin binding protein and can accelerate the folding of proteins. PPIA mRNA is not typically reduced in patients with schizophrenia in other cohorts [60, [62] [63] [64] . Thus, the reductions in PPIA mRNA that we have found may represent increased power to detect a difference (approx. 10% reduction) or may represent a fi nding specifi c to the present cohort. The other transcript we found to be decreased, SDHA, encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase, part of the mitochondrial respiratory chain complex II on the mitochondrial inner membrane. Mutations in SDHA have been associated with a form of mitochondrial respiratory chain defi ciency known as Leigh syndrome and with late-onset optic atrophy [65, 66] . Dysfunction of mitochondrial respiration can lead to cognitive decline in attention and mental
SUPPLEMENTARY MATERIAL
Methods and Materials
Subjects
The cases were accessed from the New South Wales Tissue Resource One patient with a comorbid diagnosis for alcohol dependency and another schizophrenia patient with comorbid drug abuse at the time of death were included in the cohort. Potential donors who had undergone assisted ventilation for more than 24 hours prior to death, or with a prolonged agonal status, were also excluded from the collection.
Postmortem clinical diagnosis
Postmortem clinical diagnosis is a critical and vital fi rst step in the ascertainment of schizophrenia samples. While diagnosing subjects before death may be considered optimal, many brain banks receive non pre-consented donations arising from Coroner's autopsies or from donations by the family after death. For these cases, the brain bank conducts retrospective clinical interviews and record reviews after death. Standards for retrospective postmortem diagnosis have been developed using current diagnostic instruments [1] [2] [3] [4] . A postmortem clinical diagnosis is determined for each case primarily through extensive review of medical records by experienced clinicians. All available pre-mortem information is collected in relation to the donor's social, developmental, psychiatric, drug, alcohol and medical treatment history. This information is collated into a formatted, structured clinical summary, as described previously [5, 6] . If required, further information is sought from telephone interviews with the next of kin, general practitioners and specialist health personnel.
A DSM-IV diagnosis (American Psychiatric Association 1994) is generated with The Diagnostic Instrument for Brain Studies -Revised (DIBS) that is applied to the clinical summary described above [3] .
The DIBS is a semi-structured instrument specifi cally designed for postmortem psychiatric assessment using medical records and informants. It enables diagnosis at a sub-syndrome and symptom-based 
Smoking history
Smoking history was collected after review of all available medical records and information from the next of kin. This information is categorised into the following groups: non-smoker, moderate (less than one packet of 25 cigarettes per day), heavy (Ն 1 packet per day), and those who were ex-smokers (with a known period of abstinence of at least 1 year). Smoking histories were available on 59 of 74 cases. 
Manner of death
Brain anatomical dissections
Frozen tissue was dissected on a dry ice platform using a moderate speed (up to 40,000 rpm) dental drill (Cat# UP500-UG33, Brasseler, USA) to minimize heat generation during the dissection. For the DLPFC dissections (average weight of tissue ~0.5g grey matter tissue from the crown of the middle frontal gyrus was obtained from the coronal slab corresponding to the middle one-third (rostral-caudally)
found anterior to the genu of the corpus callosum.
Agonal state
The agonal status was assessed based on a 3 point scale: excellent (1), good (2) and poor (3) . The rating was assigned to each case based on information from the police report to the Coroner, and the autopsy report as per criteria previously described [7, 8] . Donors with a short agonal phase and good physical condition were rated 'excellent', those with a moderate agonal phase and average physical condition at death were rated as 'good', and donors with a longer agonal phase, and/or poor physical condition prior to death were rated 'poor'. Since no cases met the criteria for prolonged agonal state (from extended hospital stay before death), this category (rated 4 in previous publications) [7, 8] was not used.
Age at death and postmortem interval
Age at death was verifi ed by obtaining both the date of birth and the date of death from next of kin consent forms and medical records.
Postmortem interval was calculated from the time a person was last seen alive (or the time of death, if known) to the time when the fresh tissue dissection of the brain commenced.
Tissue dissection
At autopsy, brain weight and volume were determined [9] and the brain was photographed prior to and after tissue preparation. The cerebrum, cerebellum and brainstem were divided in the sagittal plane. The cerebellar hemisphere and brainstem were removed from each cerebral hemisphere by transversely sectioning the brainstem through the rostral midbrain at the level of the superior colliculi. Each cerebral hemisphere and its contralateral cerebellar hemisphere and brainstem were assigned a 'fresh' or 'fi xed' status on a random basis. The fresh hemisphere was cut into ~1 cm coronal slices and the prefrontal, anterior and posterior cingulate, visual, superior temporal and motor frontal cortices, caudate putamen, basal forebrain, amygdala, thalamus and hippocampus anatomical areas were dissected for separate freezing. The dissected tissue blocks and remaining slices were immediately frozen to a temperature of -80°C. Frozen blocks and slices were then stored at -80°C (±5°C) in air tight snap-lock plastic bags. The remaining cerebral hemisphere was fi xed in 15% buffered formalin for 3 weeks and prepared for histology and neuropathological examination by a qualifi ed neuropathologist as previously described [6] . The macroscopic and microscopic neuropathological reports were used to establish the suitability of each case for research.
pH measurement
To assess tissue integrity 1g of fresh cerebellar tissue was homogenized in 10 mLs of distilled water [10] [11] [12] . pH was measured in triplicate using a temperature compensating Mettler Toledo MP220 pH meter (Mettler USA). For this study, an additional pH measurement was taken using 0.1g of pulverized dorsal lateral prefrontal cortex C.S. WEICKERT, D. SHEEDY, D.A. ROTHMOND ET AL. Table 1S . Detailed cohort demographic information. 
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